Sandeep Soni, MD

Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies. Areas of Interest- - Cellular Therapy - Gene Therapy - Stem Cell Transplant - Sickle Cell Disease - Thalassemia - Reduced Intensity Conditioning Clinical Focus- - Hematology/Oncology - Stem Cell Transplant and Gene Therapy Online profile